Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1134 entries
Sorted by: Best Match Show Resources per page
Flipped classroom model: effects on performance, attitudes and perceptions in high school algebra

flipped classroom

Esperanza P, Fabian K, Toto C.
GSID: egwhSFbsPjIJ
P Esperanza, K Fabian, C Toto - European Conference on Technology …, 2016 - Springer

… the flipped classroom model and its effects to students’ performance and attitudes to mathematics. A randomized controlled trial with 91 high school algebra students was conducted. The experimental group participated in a year-long intervention of the flipped classroom...

Cite
Esperanza, P., Fabian, K., & Toto, C. (2016, September). Flipped classroom model: effects on performance, attitudes and perceptions in high school algebra. In European Conference on Technology Enhanced Learning (pp. 85-97). Springer, Cham.
Esperanza, Peter, Khristin Fabian, and Criselda Toto. "Flipped classroom model: effects on performance, attitudes and perceptions in high school algebra." European Conference on Technology Enhanced Learning. Springer, Cham, 2016.
Copy Download .nbib Format: MLA
Model project based learning (PjBL) berbasis STEM untuk meningkatkan penguasaan konsep dan keterampilan berpikir kritis siswa

Research training stem

Ilmiyati N, Toto T.
GSID: Mq98blZG0t4J
AN Afifah, N Ilmiyati, T Toto - Quagga: Jurnal Pendidikan Dan …, 2019 - journal.uniku.ac.id

… Tujuan penelitian ini adalah untuk mengetahui model PjBL berbasis STEM dalam meningkatkan … Hasil penelitian disimpulkan bahwa model PjBL berbasis STEM dapat meningkatkan …

Cite
Afifah, A. N., Ilmiyati, N., & Toto, T. (2019). Model project based learning (PjBL) berbasis STEM untuk meningkatkan penguasaan konsep dan keterampilan berpikir kritis siswa. Quagga: Jurnal Pendidikan Dan Biologi, 11(2), 73-78.
Afifah, Afni Nur, Nur Ilmiyati, and Toto Toto. "Model project based learning (PjBL) berbasis STEM untuk meningkatkan penguasaan konsep dan keterampilan berpikir kritis siswa." Quagga: Jurnal Pendidikan Dan Biologi 11.2 (2019): 73-78.
Copy Download .nbib Format: MLA
Corrigendum: Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions.

Scientific reports

Mastropasqua R, Toto L, Di Antonio L, Borrelli E, Senatore A, Di Nicola M, Di Martino G, Ciancaglini M, Carpineto P.
PMID: 28230055
Sci Rep. 2017 Feb 23;7:42570. doi: 10.1038/srep42570.

No abstract available.

Cite
Mastropasqua R, Toto L, Di Antonio L, et al. Corrigendum: Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions. Sci Rep. 2017;7:42570doi: 10.1038/srep42570.
Mastropasqua, R., Toto, L., Di Antonio, L., Borrelli, E., Senatore, A., Di Nicola, M., Di Martino, G., Ciancaglini, M., & Carpineto, P. (2017). Corrigendum: Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions. Scientific reports, 742570. https://doi.org/10.1038/srep42570
Mastropasqua, Rodolfo, et al. "Corrigendum: Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions." Scientific reports vol. 7 (2017): 42570. doi: https://doi.org/10.1038/srep42570
Mastropasqua R, Toto L, Di Antonio L, Borrelli E, Senatore A, Di Nicola M, Di Martino G, Ciancaglini M, Carpineto P. Corrigendum: Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions. Sci Rep. 2017 Feb 23;7:42570. doi: 10.1038/srep42570. PMID: 28230055; PMCID: PMC5322569.
Copy Download .nbib Format: NLM
Guidelines for quality control of PET/CT scans in a multicenter clinical study.

EJNMMI physics

Hristova I, Boellaard R, Galette P, Shankar LK, Liu Y, Stroobants S, Hoekstra OS, Oyen WJG.
PMID: 28924696
EJNMMI Phys. 2017 Sep 18;4(1):23. doi: 10.1186/s40658-017-0190-7.

To date, there is no published detailed checklist with parameters referencing the DICOM tag information with respect to the quality control (QC) of PET/CT scans. The aims of these guidelines are to provide the know-how for effectively controlling the...

Cite
Hristova I, Boellaard R, Galette P, et al. Guidelines for quality control of PET/CT scans in a multicenter clinical study. EJNMMI Phys. 2017;4(1):23doi: 10.1186/s40658-017-0190-7.
Hristova, I., Boellaard, R., Galette, P., Shankar, L. K., Liu, Y., Stroobants, S., Hoekstra, O. S., & Oyen, W. J. G. (2017). Guidelines for quality control of PET/CT scans in a multicenter clinical study. EJNMMI physics, 4(1), 23. https://doi.org/10.1186/s40658-017-0190-7
Hristova, Ivalina, et al. "Guidelines for quality control of PET/CT scans in a multicenter clinical study." EJNMMI physics vol. 4,1 (2017): 23. doi: https://doi.org/10.1186/s40658-017-0190-7
Hristova I, Boellaard R, Galette P, Shankar LK, Liu Y, Stroobants S, Hoekstra OS, Oyen WJG. Guidelines for quality control of PET/CT scans in a multicenter clinical study. EJNMMI Phys. 2017 Sep 18;4(1):23. doi: 10.1186/s40658-017-0190-7. PMID: 28924696; PMCID: PMC5603471.
Copy Download .nbib Format: NLM
Generalized Moment Method for Gap Estimation and Quantum Monte Carlo Level Spectroscopy.

Physical review letters

Suwa H, Todo S.
PMID: 26340171
Phys Rev Lett. 2015 Aug 21;115(8):080601. doi: 10.1103/PhysRevLett.115.080601. Epub 2015 Aug 17.

We formulate a convergent sequence for the energy gap estimation in the worldline quantum Monte Carlo method. The ambiguity left in the conventional gap calculation for quantum systems is eliminated. Our estimation will be unbiased in the low-temperature limit,...

Cite
Suwa H, Todo S. Generalized Moment Method for Gap Estimation and Quantum Monte Carlo Level Spectroscopy. Phys Rev Lett. 2015;115(8):080601doi: 10.1103/PhysRevLett.115.080601.
Suwa, H., & Todo, S. (2015). Generalized Moment Method for Gap Estimation and Quantum Monte Carlo Level Spectroscopy. Physical review letters, 115(8), 080601. https://doi.org/10.1103/PhysRevLett.115.080601
Suwa, Hidemaro, and Todo, Synge. "Generalized Moment Method for Gap Estimation and Quantum Monte Carlo Level Spectroscopy." Physical review letters vol. 115,8 (2015): 080601. doi: https://doi.org/10.1103/PhysRevLett.115.080601
Suwa H, Todo S. Generalized Moment Method for Gap Estimation and Quantum Monte Carlo Level Spectroscopy. Phys Rev Lett. 2015 Aug 21;115(8):080601. doi: 10.1103/PhysRevLett.115.080601. Epub 2015 Aug 17. PMID: 26340171.
Copy Download .nbib Format: NLM
Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents.

European heart journal. Cardiovascular pharmacotherapy

Goto S, Goto S.
PMID: 27533961
Eur Heart J Cardiovasc Pharmacother. 2015 Jan;1(1):29-30. doi: 10.1093/ehjcvp/pvu014. Epub 2015 Jan 01.

No abstract available.

Cite
Goto S, Goto S. Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents. Eur Heart J Cardiovasc Pharmacother. 2015;1(1):29-30doi: 10.1093/ehjcvp/pvu014.
Goto, S., & Goto, S. (2015). Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents. European heart journal. Cardiovascular pharmacotherapy, 1(1), 29-30. https://doi.org/10.1093/ehjcvp/pvu014
Goto, Shinichi, and Goto, Shinya. "Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents." European heart journal. Cardiovascular pharmacotherapy vol. 1,1 (2015): 29-30. doi: https://doi.org/10.1093/ehjcvp/pvu014
Goto S, Goto S. Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents. Eur Heart J Cardiovasc Pharmacother. 2015 Jan;1(1):29-30. doi: 10.1093/ehjcvp/pvu014. Epub 2015 Jan 01. PMID: 27533961.
Copy Download .nbib Format: NLM
Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants?.

European heart journal. Cardiovascular pharmacotherapy

Goto S, Goto S.
PMID: 27533975
Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):83-5. doi: 10.1093/ehjcvp/pvu017. Epub 2015 Feb 19.

No abstract available.

Cite
Goto S, Goto S. Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants?. Eur Heart J Cardiovasc Pharmacother. 2015;1(2):83-5doi: 10.1093/ehjcvp/pvu017.
Goto, S., & Goto, S. (2015). Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants?. European heart journal. Cardiovascular pharmacotherapy, 1(2), 83-5. https://doi.org/10.1093/ehjcvp/pvu017
Goto, Shinichi, and Goto, Shinya. "Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants?." European heart journal. Cardiovascular pharmacotherapy vol. 1,2 (2015): 83-5. doi: https://doi.org/10.1093/ehjcvp/pvu017
Goto S, Goto S. Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants?. Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):83-5. doi: 10.1093/ehjcvp/pvu017. Epub 2015 Feb 19. PMID: 27533975.
Copy Download .nbib Format: NLM
Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy.

Cell transplantation

Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai H, Todo S.
PMID: 28863749
Cell Transplant. 2008 Sep;17(9):1083-1094. doi: 10.3727/096368908786991542.

For future cell-based therapies for liver diseases, the shortage of cell sources must be resolved. Immortalized human hepatocytes are expected to be among the new sources. In addition to telomerase activation by the introduction of human telomerase reverse transcriptase...

Cite
Tsuruga Y, Kiyono T, Matsushita M, et al. Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy. Cell Transplant. 2008;17(9):1083-1094doi: 10.3727/096368908786991542.
Tsuruga, Y., Kiyono, T., Matsushita, M., Takahashi, T., Kasai, H., & Todo, S. (2008). Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy. Cell transplantation, 17(9), 1083-1094. https://doi.org/10.3727/096368908786991542
Tsuruga, Yosuke, et al. "Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy." Cell transplantation vol. 17,9 (2008): 1083-1094. doi: https://doi.org/10.3727/096368908786991542
Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai H, Todo S. Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy. Cell Transplant. 2008 Sep;17(9):1083-1094. doi: 10.3727/096368908786991542. PMID: 28863749.
Copy Download .nbib Format: NLM
Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).

Brain sciences

Kawarai T, Morigaki R, Kaji R, Goto S.
PMID: 28672841
Brain Sci. 2017 Jun 26;7(7). doi: 10.3390/brainsci7070072.

X-linked dystonia-parkinsonism (XDP; OMIM314250), also referred to as DYT3 dystonia or "Lubag" disease, was first described as an endemic disease in the Philippine island of Panay. XDP is an adult-onset movement disorder characterized by progressive and severe dystonia followed...

Cite
Kawarai T, Morigaki R, Kaji R, et al. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag). Brain Sci. 2017;7(7)doi: 10.3390/brainsci7070072.
Kawarai, T., Morigaki, R., Kaji, R., & Goto, S. (2017). Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag). Brain sciences, 7(7), . https://doi.org/10.3390/brainsci7070072
Kawarai, Toshitaka, et al. "Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag)." Brain sciences vol. 7,7 (2017). doi: https://doi.org/10.3390/brainsci7070072
Kawarai T, Morigaki R, Kaji R, Goto S. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag). Brain Sci. 2017 Jun 26;7(7). doi: 10.3390/brainsci7070072. PMID: 28672841; PMCID: PMC5532585.
Copy Download .nbib Format: NLM
Thoracoscopic treatment of recurrent pneumothorax by pleurabrushing and argon beam coagulation.

Surgical technology international

Asfour B, Förster R, Geiger AW, Toth S, Scheld HH, Thülig B.
PMID: 25951547
Surg Technol Int. 1993 Oct;2:89-91.

There is no consensus in treating relapsing pneumothorax and pleural effusion. Various types of treatment exist. While open chest surgery with mechanical pleurodesis or pleurectomy is effective, with a recurrence rate close to zero, for patients in poor conditions...

Cite
Asfour B, Förster R, Geiger AW, et al. Thoracoscopic treatment of recurrent pneumothorax by pleurabrushing and argon beam coagulation. Surg Technol Int. 1993;2:89-91
Asfour, B., Förster, R., Geiger, A. W., Toth, S., Scheld, H. H., & Thülig, B. (1993). Thoracoscopic treatment of recurrent pneumothorax by pleurabrushing and argon beam coagulation. Surgical technology international, 289-91.
Asfour, B, et al. "Thoracoscopic treatment of recurrent pneumothorax by pleurabrushing and argon beam coagulation." Surgical technology international vol. 2 (1993): 89-91.
Asfour B, Förster R, Geiger AW, Toth S, Scheld HH, Thülig B. Thoracoscopic treatment of recurrent pneumothorax by pleurabrushing and argon beam coagulation. Surg Technol Int. 1993 Oct;2:89-91. PMID: 25951547.
Copy Download .nbib Format: NLM
Technical aspects of intestinal transplantation.

Surgical technology international

Furukawa H, Abu-Elmagd K, Reyes J, Nour B, Tzakis A, Todo S, Starzl TE.
PMID: 25951558
Surg Technol Int. 1993 Oct;2:165-70.

Since the advent of the potent immunosuppressive agent FK 506, intestinal transplantation has become a feasible therapeutic option for patients with irreversible intestinal failure. In this chapter, we present our clinical experience with intestinal transplantation, focusing on the technical...

Cite
Furukawa H, Abu-Elmagd K, Reyes J, et al. Technical aspects of intestinal transplantation. Surg Technol Int. 1993;2:165-70
Furukawa, H., Abu-Elmagd, K., Reyes, J., Nour, B., Tzakis, A., Todo, S., & Starzl, T. E. (1993). Technical aspects of intestinal transplantation. Surgical technology international, 2165-70.
Furukawa, H, et al. "Technical aspects of intestinal transplantation." Surgical technology international vol. 2 (1993): 165-70.
Furukawa H, Abu-Elmagd K, Reyes J, Nour B, Tzakis A, Todo S, Starzl TE. Technical aspects of intestinal transplantation. Surg Technol Int. 1993 Oct;2:165-70. PMID: 25951558.
Copy Download .nbib Format: NLM
Zoledronate-pulsed dendritic cell-based anticancer vaccines.

Oncoimmunology

Kamigaki T, Takahara M, Maekawa R, Goto S.
PMID: 24319636
Oncoimmunology. 2013 Sep 01;2(9):e25636. doi: 10.4161/onci.25636. Epub 2013 Jul 09.

The addition of zoledronate to tumor-associated antigen (TAA)-loaded dendritic cells (DCs) promotes the activation of interferon γ-secreting Vγ9 γδ T cells, in turn eliciting TAA-specific CD8

Cite
Kamigaki T, Takahara M, Maekawa R, et al. Zoledronate-pulsed dendritic cell-based anticancer vaccines. Oncoimmunology. 2013;2(9):e25636doi: 10.4161/onci.25636.
Kamigaki, T., Takahara, M., Maekawa, R., & Goto, S. (2013). Zoledronate-pulsed dendritic cell-based anticancer vaccines. Oncoimmunology, 2(9), e25636. https://doi.org/10.4161/onci.25636
Kamigaki, Takashi, et al. "Zoledronate-pulsed dendritic cell-based anticancer vaccines." Oncoimmunology vol. 2,9 (2013): e25636. doi: https://doi.org/10.4161/onci.25636
Kamigaki T, Takahara M, Maekawa R, Goto S. Zoledronate-pulsed dendritic cell-based anticancer vaccines. Oncoimmunology. 2013 Sep 01;2(9):e25636. doi: 10.4161/onci.25636. Epub 2013 Jul 09. PMID: 24319636; PMCID: PMC3850548.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1134 entries